Drug	Gene	Type	Source
DAZOMET	NFE2L2	Text_Mining(increases(activity))	CTD
DAZOMET	AR	AR Potency (uM)=4.83109(uM)	D4 PubChem
DAZOMET	AR	Potency-Replicate_1=4.8311(uM)	D4 PubChem
DAZOMET	AR	Potency-Replicate_1=5.4316(uM)	D4 PubChem
DAZOMET	AR	Potency=15.8489(uM)	D4 PubChem
DAZOMET	CYP19A1	Potency-Replicate_1=3.8453(uM)	D4 PubChem
DAZOMET	CYP19A1	Potency-Replicate_1=4.8311(uM)	D4 PubChem
DAZOMET	DRD2	None=None(uM)	D4 PubChem
DAZOMET	HSPB1	Ratio Potency (uM)=0.37234(uM)	D4 PubChem
DAZOMET	HSPB1	Ratio Potency (uM)=0.435398(uM)	D4 PubChem
DAZOMET	IL1B	None=None(uM)	D4 PubChem
DAZOMET	INS	None=None(uM)	D4 PubChem
DAZOMET	KCNQ1	None=None(uM)	D4 PubChem
DAZOMET	NFE2L2	Ratio Potency (uM)=10.2313(uM)	D4 PubChem
DAZOMET	NFE2L2	Potency=27.306(uM)	D4 PubChem
DAZOMET	NFE2L2	Potency=42.1632(uM)	D4 PubChem
DAZOMET	NR3C1	Ratio Potency (uM)=1.72825(uM)	D4 PubChem
DAZOMET	TDP1	Potency=4.6109(uM)	D4 PubChem
DAZOMET	TDP1	Potency=6.5131(uM)	D4 PubChem
DAZOMET	VDR	None=None(uM)	D4 PubChem